Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radiofrequency Ablation Via Catheter and Transpapillary Access in Patients With Cholangiocarcinoma

NCT06175845 is registered in ClinicalTrials.gov with Universitätsklinikum Hamburg-Eppendorf as lead sponsor.

NCT NCT06175845
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06175845 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radiofrequency Ablation Via Catheter and Transpapillary Access in Patients With Cholangiocarcinoma
Lead sponsor
Universitätsklinikum Hamburg-Eppendorf
Phase
Not applicable
Overall status
Recruiting
Start date
August 30, 2024
Completion date
November 30, 2027
Enrollment
130 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

bile duct cancer, cholangiocarcinoma, klatskin tumor, liver cancer